NCT05758402View on ClinicalTrials.gov

A Randomized, Open, Parallel, Controlled, Multi-center, Interventional, Cross-sectional Study to Evaluate the Detection Rate of Psoriatic Arthritis in Korean Moderate-to-severe Psoriasis Patients, With or Without Active Screening for Arthritis in Psoriasis (ASAP Study)

NACompletedINTERVENTIONAL
Enrollment

368

Participants

Timeline

Start Date

October 20, 2022

Primary Completion Date

June 30, 2023

Study Completion Date

June 30, 2023

Conditions
Psoriasis
Interventions
DIAGNOSTIC_TEST

Routine practice group

Routine practice group

DIAGNOSTIC_TEST

EARP group

EARP group

Trial Locations (15)

13620

Novartis Investigative Site, Bundang Gu

14647

Novartis Investigative Site, Bucheon-si

41944

Novartis Investigative Site, Taegu

48108

Novartis Investigative Site, Busan

49241

Novartis Investigative Site, Busan

501171

Novartis Investigative Site, Gwangju

463-712

Novartis Investigative Site, Seongnam-si

02447

Novartis Investigative Site, Seoul

08308

Novartis Investigative Site, Seoul

03080

Novartis Investigative Site, Seoul

03722

Novartis Investigative Site, Seoul

04763

Novartis Investigative Site, Seoul

05030

Novartis Investigative Site, Seoul

07441

Novartis Investigative Site, Seoul

110-746

Novartis Investigative Site, Seoul

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY